✦ LIBER ✦

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors' reply

✍ Scribed by Bryan H Burmeister; B Mark Smithers

Book ID: 117783684
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 62 KB
Volume: 6
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(05)70402-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemoradiotherapy in resecta

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

✍ CS Pramesh; Rajesh C Mistry; Sarbani G Laskar 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 272 KB

Neoadjuvant Chemoradiotherapy for Resect

Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastro-oesophageal Junction Cancer—Do We Need Another Randomised Trial?

✍ M. Hingorani; T. Crosby; A. Maraveyas; S. Dixit; A. Bateman; R. Roy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Effect of neoadjuvant chemoradiotherapy

Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer

✍ C. O. McDonnell; D. J. Bouchier-Hayes; D. Toomey; D. Foley; E. W. Kay; E. Leen; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

Combined intensive chemoradiotherapy for

Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer

✍ E. Roca; E. Pennella; M. Sardi; S. Carraro; M. Barugel; C. Milano; A. Fiorini; R 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Survival after neoadjuvant chemotherapy

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

✍ Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 392 KB

Prospective cohort comparison of neoadju

Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer

✍ M. A. Morgan; W. G. Lewis; T. D. L. Crosby; X. Escofet; S. A. Roberts; A. E. Bre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

## Abstract ## Background Chemotherapy and chemoradiotherapy are common neoadjuvant treatments for resectable T3 N0–1 M0 oesophageal carcinoma. The aim of this study was to compare the outcomes of these therapies in consecutive cohorts of patients. ## Methods Between January 1998 and December 20